Cross-over, Randomized, Open-label, Single-centre, Phase II Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
Latest Information Update: 20 Feb 2025
At a glance
- Drugs DP 5541 (Primary) ; Fludeoxyglucose F-18
- Indications Giant cell arteritis
- Focus Diagnostic use
- Acronyms CRAFT
Most Recent Events
- 09 Jan 2025 Status changed from not yet recruiting to recruiting.
- 13 Dec 2024 Planned initiation date changed from 1 Jun 2024 to 1 Jan 2025.
- 02 Apr 2024 New trial record